Vascular Closure Devices Market Set to Surge to USD 4.08 Billion by 2035, Growing at 7.85% CAGR | Research by SNS Insider

U.S. market projected to surpass USD 1.00 billion by 2035, while Europe advances through high PCI volumes and stricter MDR-driven vascular device standards.Austin, United States, May 22, 2026 (GLOBE ...
Nasdaq

Haemonetics Announces VASCADE MVP® Venous Vascular Closure System Gains the First and Only FDA Approval for Same-Day Discharge Following Atrial Fibrillation Ablation

The AMBULATE Same-Day Discharge Clinical Study Series demonstrates safe and effective use of VASCADE MVP in three studies to date, with more than 800 AF ablation patients discharged the same calendar ...
Yahoo Finance

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Business Wire

Vivasure Medical Announces Development of Sutureless Venous Closure Device for Use in Percutaneous Transcatheter Procedures

GALWAY, Ireland--(BUSINESS WIRE)--Vivasure Medical ®, a company pioneering novel fully absorbable technology for percutaneous vessel closure, today announced its development program for PerQseal ® ...
MD&M East

Vivasure Opens up about Securing a Top Spot in Vessel Closure Market

The explosion of innovation in valve replacement and repair markets is opening a huge opportunity for percutaneous vessel closure devices. Edward Lifesciences’s FDA nod for the Evoque Transcatheter ...
Pharmabiz

Haemonetics receives US FDA nod to expand labelling of VASCADE MVP XL venous vascular closure system

Haemonetics Corporation, a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, has announced the US Food and Drug Administration (FDA) ...
Morningstar

New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures

BOSTON, April 24, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...
TCTMD

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Use of a large-bore, plug-based vascular closure device (Manta; Teleflex) following transfemoral TAVI is associated with a higher risk of vascular complications when compared with an older ...
Business Wire

Venock Reports Safety/Efficacy of Its Automated Closure Device for Large Bore Venous Access Sites as Alternative to Standard Manual Compression of Veins/Arteries in ...

NEW YORK & MUNICH--(BUSINESS WIRE)--Venock announced today it has successfully completed the demonstration of safety and efficacy of its large bore closure system in animal studies. Venock is ...
Medindia

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

VASCADE MVP XL now approved for larger sheaths used in market-leading PFA and LAAC technologies BOSTON, March 30, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology ...
Morningstar

Haemonetics Receives FDA Approval for Expanded Labeling of the VASCADE MVP® XL Venous Vascular Closure System

BOSTON, March 30, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today ...